1-4 of 4
Joshua D. Brody, MD
Close
Sort by
Journal Articles

Immunotransplant for Mantle Cell Lymphoma: Phase I/II Study Preliminary Results

Joshua D Brody, MD, Debra Katherine Czerwinski, Victoria Carlton, Martin Moorhead, PhD, Jianbiao Zheng, PhD, Mark Klinger, PhD, Malek Faham, MD, PhD, Ranjana Advani, MD, Holbrook E Kohrt, MD, Arash Ash Alizadeh, MD, PhD, Robert S Negrin, MD, Wen-Kai Weng, MD, PhD, Kevin Sheehan, PhD, Ronald Levy, MD
Journal: Blood
Blood (2011) 118 (21): 3068.
https://doi.org/10.1182/blood.V118.21.3068.3068
Published: 2011
Journal Articles

Efficient Transfer of CD40L mRNA into Mantle Cell Lymphoma for the Production of a Whole Tumor Cell Vaccine.

Joshua D. Brody, MD, Linhong Li, Stephanie Feller, Joseph Fratantoni, MD, Ronald Levy, MD
Journal: Blood
Blood (2007) 110 (11): 2591.
https://doi.org/10.1182/blood.V110.11.2591.2591
Published: 2007
Journal Articles

Correlation of IFN γ , CD107 and CD137 at the Single Cell Level Can Be Used To Monitor T Cell Responses in Patients after Immunotherapy.

Debra K. Czerwinski, BS, Joshua D. Brody, MD, Ronald Levy, MD
Journal: Blood
Blood (2007) 110 (11): 2306.
https://doi.org/10.1182/blood.V110.11.2306.2306
Published: 2007
Journal Articles

Preferential Proliferation of T Effectors and Tumor Protection by Adoptive Transfer of Primed Anti-Lymphoma Splenocytes into Lymphodepleted Hosts.

Joshua D. Brody, MD, Matthew Goldstein, Ronald Levy, MD
Journal: Blood
Blood (2007) 110 (11): 2753.
https://doi.org/10.1182/blood.V110.11.2753.2753
Published: 2007